The early start of hemoperfusion decreases the mortality rate among severe COVID-19 patients: A preliminary study.

Haleh MikaeiliAli TaghizadiehMasoud NazemiyehParisa RezaeifarSepideh Zununi VahedSaeid SafiriMohammad Reza ArdalanKhalil Ansarin

Published in: Hemodialysis international. International Symposium on Home Hemodialysis (2021)

The results imply that early start of hemoperfusion could be more effective and significantly reduce the mortality rate among COVID-19 patients with critical diseases.

Keyphrases

sars cov
cardiovascular events
coronavirus disease
septic shock
risk factors
early onset
cardiovascular disease
type diabetes
respiratory syndrome coronavirus